525 related articles for article (PubMed ID: 16968692)
1. Atypical haemolytic uraemic syndrome.
Kavanagh D; Goodship TH; Richards A
Br Med Bull; 2006; 77-78():5-22. PubMed ID: 16968692
[TBL] [Abstract][Full Text] [Related]
2. Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndrome.
Richards A; Kathryn Liszewski M; Kavanagh D; Fang CJ; Moulton E; Fremeaux-Bacchi V; Remuzzi G; Noris M; Goodship TH; Atkinson JP
Mol Immunol; 2007 Jan; 44(1-3):111-22. PubMed ID: 16882452
[TBL] [Abstract][Full Text] [Related]
3. The development of atypical haemolytic-uraemic syndrome is influenced by susceptibility factors in factor H and membrane cofactor protein: evidence from two independent cohorts.
Fremeaux-Bacchi V; Kemp EJ; Goodship JA; Dragon-Durey MA; Strain L; Loirat C; Deng HW; Goodship TH
J Med Genet; 2005 Nov; 42(11):852-6. PubMed ID: 15784724
[TBL] [Abstract][Full Text] [Related]
4. Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome.
Fremeaux-Bacchi V; Moulton EA; Kavanagh D; Dragon-Durey MA; Blouin J; Caudy A; Arzouk N; Cleper R; Francois M; Guest G; Pourrat J; Seligman R; Fridman WH; Loirat C; Atkinson JP
J Am Soc Nephrol; 2006 Jul; 17(7):2017-25. PubMed ID: 16762990
[TBL] [Abstract][Full Text] [Related]
5. The decay accelerating factor mutation I197V found in hemolytic uraemic syndrome does not impair complement regulation.
Kavanagh D; Burgess R; Spitzer D; Richards A; Diaz-Torres ML; Goodship JA; Hourcade DE; Atkinson JP; Goodship TH
Mol Immunol; 2007 May; 44(12):3162-7. PubMed ID: 17368771
[TBL] [Abstract][Full Text] [Related]
6. The interactive Factor H-atypical hemolytic uremic syndrome mutation database and website: update and integration of membrane cofactor protein and Factor I mutations with structural models.
Saunders RE; Abarrategui-Garrido C; Frémeaux-Bacchi V; Goicoechea de Jorge E; Goodship TH; López Trascasa M; Noris M; Ponce Castro IM; Remuzzi G; Rodríguez de Córdoba S; Sánchez-Corral P; Skerka C; Zipfel PF; Perkins SJ
Hum Mutat; 2007 Mar; 28(3):222-34. PubMed ID: 17089378
[TBL] [Abstract][Full Text] [Related]
7. Thrombotic microangiopathies: thrombotic thrombocytopenic purpura / hemolytic uremic syndrome.
Polito MG; Kirsztajn GM
J Bras Nefrol; 2010; 32(3):303-15. PubMed ID: 21103695
[TBL] [Abstract][Full Text] [Related]
8. Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome.
Sellier-Leclerc AL; Fremeaux-Bacchi V; Dragon-Durey MA; Macher MA; Niaudet P; Guest G; Boudailliez B; Bouissou F; Deschenes G; Gie S; Tsimaratos M; Fischbach M; Morin D; Nivet H; Alberti C; Loirat C;
J Am Soc Nephrol; 2007 Aug; 18(8):2392-400. PubMed ID: 17599974
[TBL] [Abstract][Full Text] [Related]
9. Genetic disorders in complement (regulating) genes in patients with atypical haemolytic uraemic syndrome (aHUS).
Westra D; Volokhina E; van der Heijden E; Vos A; Huigen M; Jansen J; van Kaauwen E; van der Velden T; van de Kar N; van den Heuvel L
Nephrol Dial Transplant; 2010 Jul; 25(7):2195-202. PubMed ID: 20106822
[TBL] [Abstract][Full Text] [Related]
10. [Atypical hemolytic-uremic syndrome related to abnormalities within the complement system].
Frémeaux-Bacchi V; Fakhouri F; Roumenina L; Dragon-Durey MA; Loirat C
Rev Med Interne; 2011 Apr; 32(4):232-40. PubMed ID: 21376430
[TBL] [Abstract][Full Text] [Related]
11. The role of defective complement control in hemolytic uremic syndrome.
Zipfel PF; Misselwitz J; Licht C; Skerka C
Semin Thromb Hemost; 2006 Mar; 32(2):146-54. PubMed ID: 16575689
[TBL] [Abstract][Full Text] [Related]
12. Membrane cofactor protein and factor I: mutations and transplantation.
Kavanagh D; Goodship TH
Semin Thromb Hemost; 2006 Mar; 32(2):155-9. PubMed ID: 16575690
[TBL] [Abstract][Full Text] [Related]
13. Hemolytic uremic syndrome: an example of insufficient complement regulation on self-tissue.
Atkinson JP; Liszewski MK; Richards A; Kavanagh D; Moulton EA
Ann N Y Acad Sci; 2005 Nov; 1056():144-52. PubMed ID: 16387683
[TBL] [Abstract][Full Text] [Related]
14. Haemolytic uraemic syndrome: an overview.
Amirlak I; Amirlak B
Nephrology (Carlton); 2006 Jun; 11(3):213-8. PubMed ID: 16756634
[TBL] [Abstract][Full Text] [Related]
15. Unusual clinical severity of complement membrane cofactor protein-associated hemolytic-uremic syndrome and uniparental isodisomy.
Fremeaux-Bacchi V; Sanlaville D; Menouer S; Blouin J; Dragon-Durey MA; Fischbach M; Vekemans M; Fridman WH
Am J Kidney Dis; 2007 Feb; 49(2):323-9. PubMed ID: 17261436
[TBL] [Abstract][Full Text] [Related]
16. Atypical haemolytic uraemic syndrome and mutations in complement regulator genes.
Dragon-Durey MA; Frémeaux-Bacchi V
Springer Semin Immunopathol; 2005 Nov; 27(3):359-74. PubMed ID: 16189652
[TBL] [Abstract][Full Text] [Related]
17. Atypical hemolytic uremic syndrome: update on the complement system and what is new.
Hirt-Minkowski P; Dickenmann M; Schifferli JA
Nephron Clin Pract; 2010; 114(4):c219-35. PubMed ID: 20090363
[TBL] [Abstract][Full Text] [Related]
18. Insights into hemolytic uremic syndrome: segregation of three independent predisposition factors in a large, multiple affected pedigree.
Esparza-Gordillo J; Jorge EG; Garrido CA; Carreras L; López-Trascasa M; Sánchez-Corral P; de Córdoba SR
Mol Immunol; 2006 Apr; 43(11):1769-75. PubMed ID: 16386793
[TBL] [Abstract][Full Text] [Related]
19. Inherited deficiency of membrane cofactor protein expression and varying manifestations of recurrent atypical hemolytic uremic syndrome in a sibling pair.
Couzi L; Contin-Bordes C; Marliot F; Sarrat A; Grimal P; Moreau JF; Merville P; Fremeaux-Bacchi V
Am J Kidney Dis; 2008 Aug; 52(2):e5-9. PubMed ID: 18514989
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies in haemolytic uraemic syndrome (HUS).
Skerka C; Józsi M; Zipfel PF; Dragon-Durey MA; Fremeaux-Bacchi V
Thromb Haemost; 2009 Feb; 101(2):227-32. PubMed ID: 19190803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]